Why is Direct Detection so Important?
Clinical studies funded by the NIH/NEI have shown that screening with blinq is a dramatically more accurate approach to measuring for amblyopia than methods which merely collect data on amblyopic risk factors (ARF).* Greater accuracy leads to a reduction in care costs while improving patient outcomes.
Contact us for more information.
Why choose blinq?
The blinq Advantage
Reduces costly over-referrals by 70% versus ARF screening
Is 97% sensitive at detecting actual disease while ARF methods generally yield only 85% sensitivity at detecting the less rigorous metric of risk factors for disease
blinq screening may be reimbursable under category III CPT code 0469T “retinal polarization scan, ocular screening with on-site automated results, bilateral”
Definitive “pass” and “refer” output for amblyopia, including refractive amblyopia, micro-strabismus and strabismus
Eliminates interpretation of confounding data
Easy to Implement
Ergonomically designed for portable screening where children congregate
Ambidextrous orb design is easy to hold and unassuming to patients
Captivating target challenges patients visual function
blinq is designed to meet today’s screening needs
Encrypted data enables screening programs to remain HIPAA compliant and secure patient privacy
Intuitive data management applications on the device and tandem web-based tools
Wirelessly “push” patient lists to blinq and “pull” screening results, eliminating the paper-trail and floating USB sticks